Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,143,491)	$ (1,302,113)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	106,793	340,321
Noncash stock-based compensation expense	298,030	88,525
Deferred rent	(8,779)	(6,519)
Changes in assets and liabilities:
Decrease in accounts receivable	467,911	204,853
(Increase) Decrease in inventory	(1,479)	3,115
Decrease (Increase) in other current assets	$ 19,343	(30,115)
Decrease in other assets		9,206
Increase in accounts payable, accrued expenses	$ 395,120	132,117
Increase (Decrease) in deferred revenue	97,340	(146,460)
Net cash used in operating activities	$ (769,212)	(707,070)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of patents		(125,000)
Purchases of property and equipment	$ (22,747)	$ (28,671)
Collection on note receivable	9,577
Net cash used in investing activities	$ (13,170)	$ (153,671)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock		$ 7,630,757
Purchase and retirement of common stock	$ (1,096,608)
Payments on note payable		$ (1,620)
Net cash (used in) provided by financing activities	$ (1,096,608)	7,629,137
Net (decrease) increase in cash and cash equivalents	(1,878,990)	6,768,396
CASH AND CASH EQUIVALENTS, beginning of period	5,953,257	2,966,350
CASH AND CASH EQUIVALENTS, end of period	$ 4,074,267	9,734,746
Supplemental disclosure of noncash investing and financing activities:
Financing of property and equipment		$ 31,078